Insights Into NTRK Gene Fusion-Positive NSCLC

Perspectives on testing protocols and treatment pathways for NTRK gene fusion-positive NSCLC

Southwest – March 28, 2022
Purchase Report

Faculty Chair

Luis Raez, MD

Memorial Cancer Institute, Hollywood, FL, USA

More Information

  • Virtual series
  • Arizona, California, Colorado

Example Report

Start discovering the insights

View Report

REPORT SNAPSHOT

  • A moderated roundtable discussion was held with community oncologists from the Southwest US region in a virtual setting on March 28, 2022
  • Disease-state and data presentations were led by Dr Luis Raez, Chief Scientific Officer and Medical Director at Memorial Cancer Institute in Florida, in conjunction with content developed by the Aptitude Health clinical team
  • Insights were obtained on testing protocols and treatment pathways in NTRK gene fusion-positive NSCLC in the community setting

GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT

  • Data collection was accomplished through use of audience response system questioning and in-depth moderated discussion
  • The group of advisors comprises 11 oncologists from Arizona, California, and Colorado

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.